Author: BusinessWire

March 10, 2021 Off

Global Laboratory Automation Systems Market Outlook 2021-2025 – Growing Use of Automated Solutions in Healthcare and High Demand for Protein Crystallization and Crystallography Driving Growth – ResearchAndMarkets.com

By BusinessWire

DUBLIN–(BUSINESS WIRE)–The “Global Laboratory Automation Systems Market 2021-2025” report has been added to ResearchAndMarkets.com’s offering.

The laboratory automation systems market is poised to grow by $1.47 billion during 2021-2025, progressing …

March 10, 2021 Off

Global Laboratory Automation Systems Market Outlook 2021-2025 – Growing Use of Automated Solutions in Healthcare and High Demand for Protein Crystallization and Crystallography Driving Growth – ResearchAndMarkets.com

By BusinessWire

DUBLIN–(BUSINESS WIRE)–The “Global Laboratory Automation Systems Market 2021-2025” report has been added to ResearchAndMarkets.com’s offering.

The laboratory automation systems market is poised to grow by $1.47 billion during 2021-2025, progressing …

March 10, 2021 Off

Global Laboratory Automation Systems Market Outlook 2021-2025 – Growing Use of Automated Solutions in Healthcare and High Demand for Protein Crystallization and Crystallography Driving Growth – ResearchAndMarkets.com

By BusinessWire

DUBLIN–(BUSINESS WIRE)–The “Global Laboratory Automation Systems Market 2021-2025” report has been added to ResearchAndMarkets.com’s offering.

The laboratory automation systems market is poised to grow by $1.47 billion during 2021-2025, progressing …

March 10, 2021 Off

Global Laboratory Automation Systems Market Outlook 2021-2025 – Growing Use of Automated Solutions in Healthcare and High Demand for Protein Crystallization and Crystallography Driving Growth – ResearchAndMarkets.com

By BusinessWire

DUBLIN–(BUSINESS WIRE)–The “Global Laboratory Automation Systems Market 2021-2025” report has been added to ResearchAndMarkets.com’s offering.

The laboratory automation systems market is poised to grow by $1.47 billion during 2021-2025, progressing …

March 10, 2021 Off

NT-814 by Bayer: A Non-Hormonal, Orally Administered, Potent and Selective Small Molecule Dual Antagonist of Neurokinin-1 and 3 receptors – Global Emerging Insight and Market Forecast to 2030 – ResearchAndMarkets.com

By BusinessWire

DUBLIN–(BUSINESS WIRE)–The “NT-814 – Emerging Insight and Market Forecast – 2030” report has been added to ResearchAndMarkets.com’s offering.

This report provides a detailed market assessment of NT-814 in Seven Major Markets, i.e., United States, EU…